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Abstract Ketotifen was immobilised in cellulose acetate
propionate (CAP) membranes and in cellulose acetate
butyrate (CAB) membranes. The characteristics of each
system were evaluated under a range of experimental
conditions. The topography and uniformity of the mem-
branes was assessed using scanning electron microscopy.
The release characteristics associated with Ketotifen were
monitored spectrophotometrically. The swelling capacity
of the membranes was evaluated and attributed to the
combined effects of diffusion and of complex dissociation,
during swelling. The materials produced were able to
provide controlled release of Ketotifen due to their con-
trolled swelling behaviour and adequate release properties.
The results showed that the release of Ketotifen from the
CAB membranes is higher but the release from the CAP
membranes is more uniform.
Introduction
The application of controlled release systems, in which
biologically active substances are released to their envi-
ronment with controllable rates, has recently grown enor-
mously. The controlled administration of chemicals or
drugs is widely publicised in the field of medicine and
pharmacy, agriculture, food industry and biotechnology
[1–5].
In the preparation of these materials, the biologically
active substance is immobilised in/on a carrier, generally a
polymeric material. These polymeric systems must have
the right balance of hydrophobicity/hydrophilicity, the
right charge character and, if used as a biomaterial, they
must be biocompatible. Their form (powder, fibre or
membrane) is dependent on the application. Membranes
can be used as a carrier in which the bioactive compounds
can be attached to the surface of the membrane or en-
trapped within the polymer network. In this area, mem-
brane composites of cellulose are well known controlled
release agents for a large number of compounds [6–11].
In this article we report the results obtained when Ke-
totifen, an important anti-histaminic and anti-anaphylactic
drug [12–17], was immobilised by entrapment in cellulose
acetate propionate (CAP) and in cellulose acetate butyrate
(CAB) membranes, that constitute extremely useful exter-
nal biocompatible bandages for drug release.
Ketotifen is a widely used prophylactic antiasthmatic
drug with pronounced antianaphylactic properties and a
specific H1-antihistaminic effect. Asthma, a complex dis-
ease with an aetiology characterized by reversible episodes
of airflow obstruction, airway hyper responsiveness and a
chronic inflammatory process of the airways, affects more
than 300 million individuals in world. Almost 90% of the
cases have their origins in childhood and the last decades
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showed significant increases in asthma prevalence, hospi-
talization, health care utilization and mortality rates. De-
spite the availability of several classes of therapeutic agents
for asthma, it has been estimated that as many as one-half
of asthmatic patients do not respond to treatment with b2-
agonists, LT antagonists, or inhaled corticosteroids, pre-
senting a large potential for drug development.
In parallel with this, the development of controlled re-
lease systems of antiasthmatic antianaphylactic drugs is
expected to grow significantly, to avoid acute over dosage.
Ketotifen is a perfect candidate for the development of
controlled release systems of antiasthmatic antianaphylac-
tic compounds. Its acute toxicity is rather low, since no
serious effects have been reported either in children or in
adults after the intake of up to 20 mg of ketotifen, which is
10 times the recommended dose and it is well tolerated
specially by the children. Ketotifen also induces a moder-
ate to marked symptom improvement in the majority of
patients with atopic dermatitis, seasonal or perennial rhi-
nitis, allergic conjunctivitis, chronic or acute urticaria [18–
20].
Experimental section
Cellulose acetate butyrate and cellulose acetate propionate
were supplied by Eastman Chemical Co. Ltd., Workington,
Cumbria, UK, and Ketotifen (fumarate salt) was obtained
from Sigma Chemical Company, Poole, Dorset, UK.
Membrane preparation
Various solutions of cellulose acetate butyrate (CAB) in
tetrahydrofuran (THF) and cellulose acetate propionate
(CAP) in THF were prepared in the following way: each
component of each solution was mixed with THF, on the
basis that the ratio polymer/THF should be 20:80 (by
weight). These solutions were maintained at room tem-
perature (25 C) with strong stirring for 48 h, to ensure
homogeneity of the solutions. The solutions were then cast
on 20 · 20 cm glass plates. The solvent was evaporated at
room temperature for 3 h, resulting in 0.3 mm thick
membranes. Previous studies (DSC and TGA) [21] showed
that such treatments provided membranes that were free of
residual solvents.
Ketotifen entrapment in the membranes
Various solutions of Ketotifen in tetrahydrofuran (THF) at
the desired concentrations were added to the membrane
pre-solutions in THF to obtain the membranes used in the
studies.
Determination of the immobilised Ketotifen in the
membranes
Portions of the membranes (50 mg), containing the en-
trapped Ketotifen, were dissolved in THF (5 cm3). The
amount of Ketotifen in the solution was determined by
monitoring the absorption at 295 nm, using as a blank a
solution containing 50 mg of the membrane without Ke-
totifen, in THF (5 cm3). The absorbance values were
converted into the equivalent mg of Ketotifen, using a
calibration curve for the pure Ketotifen in THF.
Scanning electron microscopy (SEM)
SEM examinations were performed using a Jeol JSM
scanning electron microscope fitted with a Mamiya SLR
camera and TV recording facility, coupled to an X-ray
energy dispersion unit to determine the presence of ele-
mental sulphur, a component of Ketotifen.
In vitro drug release studies
In order to determine the variation of the drug release with
time, portions of the membranes (100 mg) that contained
Ketotifen were kept in distilled water (20 cm3) for various
intervals of time, at 25 C. The amount of drug released
was determined at 295 nm, using calibration curves for
Ketotifen, dissolved in water.
Determination of diffusion coefficient of ketotifen
Known small portions of membranes, with the same
amount of immobilised Ketotifen, were placed in distilled
water (20 cm3) at 25 C, for several time intervals, over a
period of 15 days. The absorbance of the Ketotifen was
determined at 295 nm.
Swelling capacity
The swelling capacity and the diffusion capacity were
determined as follows. The membranes (100 mg) were
incubated in distilled water (50 cm3) for various time
intervals, at 25 C. The water uptake was determined
gravimetrically as well as by spectrophotometric evalua-
tion of the solute release, at 295 nm. Diffusion coefficients
were determined using the Fick’s models as a basis.
Results and discussion
Determination of sulphur distribution
Analysis of CAP-Ketotifen and CAB-Ketotifen membranes
by ‘‘sulphur mapping’’, both at the surface and in cross-
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section, present similar results for both membrane systems
(Fig. 1). A good uniformity of Ketotifen distribution inside
the membranes was found, showing that the physical im-
mobilisation of Ketotifen was achieved by entrapment and
not by adsorption.
Determination of membrane structures
In order to relate the release results to the membrane
composition and morphology, the membranes were char-
acterised by SEM. Figure 2 show SEM of the CAP mem-
branes, with and without immobilised Ketotifen
respectively, and Fig. 3 show SEM of CAB membranes,
without and with immobilised Ketotifen respectively. Both
CAP and CAB membranes have the same amount of im-
mobilised Ketotifen.
These micrographs show that the CAB membranes
have more surface irregularities and are more porous
than CAP membranes, probably due to the different size
of the butyrate group compared with the propionate
group. Also CAB membranes have a more open struc-
ture than CAP membranes. The presence of Ketotifen
does not imply significant changes in the membrane
structure.
Fig. 1 Sulphur determination
(after Ketotifen immobilisation)
by X-ray dispersion energy
from the surface (a) and cross-
section (b) of cellulose acetate
propionate (20% w/w)
membranes. Same results for the
surface (c) and cross-section (d)
for the cellulose acetate butyrate
(20% w/w) membranes
Fig. 2 Scanning electron
micrographs of surface (a) and
cross-section (b) of cellulose
acetate propionate (20% w/w)
membranes without
immobilised Ketotifen.
Scanning electron micrographs
of surface (c) and cross-section
(d) of cellulose acetate
propionate (20% w/w)
fsmembrane, with immobilised
Ketotifen
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Study of the Ketotifen release from CAP and CAB
membranes
Figure 4 shows the Ketotifen release profile, for both CAP
and CAB systems.
These graphs show that the percentage of drug released
is higher for CAB membranes. The total percentage of the
drug released is 1.8% (w/w) for the CAB membranes and
0.6% (w/w) for the CAP membranes. These results also
show that for the 24–75 h time period the release of Ke-
totifen is much higher from the CAB membranes. In the
interval studied the concentrations of Ketotifen released are
0.1–0.5 mg/g for the CAP membranes and 0.02–3.5 mg/g
for the CAB membranes.
The variation of the release of Ketotifen from the
membranes shows a slowing down of the Ketotifen release
Fig. 3 Scanning electron
micrographs of surface (a) and
cross-section (b) of cellulose
acetate butyrate (20%)
membranes without
immobilised Ketotifen.
Scanning electron micrographs
of surface (c) and cross-section
(d) of cellulose acetate butyrate
(20% w/w) membrane with
Ketotifen immobilised
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Fig. 4 Ketotifen (mg) released
per g of membrane as a function
of time, for the (a) CAP and (b)
CAB membrane-Ketotifen
systems, using varying amounts
of immobilized Ketotifen
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after 50 h. Although the release of Ketotifen from the CAB
membranes is higher, the release from the CAP membranes
is slightly more uniform.
Determination of water sorption
The percentage of water sorption was calculated as:
% ðw=wÞ sorption of water ¼ ðMf  MiÞ=Mi  100
Here Mf is the final membrane mass after water
immersion and Mi is the initial membrane mass before
water immersion.
In order to relate the results obtained to the hydrophi-
licity of the membranes, analysis of the water sorption for
each membrane at room temperature was carried out.
Figure 5 shows the water sorption after 5 min and 24 h.
The results show that the water sorption in the both CAP
and CAB membranes are quite similar.
Determination of ketotifen release kinetics
To study the kinetics of Ketotifen release, all of the vari-
ables were kept constant, except the Ketotifen concentra-
tion. Thus, the kinetic profile developed relates to the
Ketotifen only. Thus,
v ¼ k ½Ketotifenn
and
log vo ¼ log k þ n log ½Ketotifeno
The first derivative of the release curves was used to
determine log vo and log k. Figure 6 shows the data used to
determinate the kinetic order for the release process rele-
vant to the CAP system and to the CAB system, respec-
tively.
The values for (n), the kinetic orders of the Ketotifen
release process are:
Release from CAP membranes n ¼ 1:89
Release from CAB membranes n ¼ 2:43
The release characteristics of these systems do not fol-
low a zero order profile, indicating that the diffusion
mechanism may be Fickian, mainly due to the membrane
morphology.
Diffusion coefficient of ketotifen
Following the kinetic evaluations, the variation in the dif-
fusion coefficient, as a function of the amount of Ketotifen
immobilized in the membranes, was established. The dif-
fusion coefficients were obtained by Fick’s second law
using all of the experimental values. The initial release of
Ketotifen is constant. The diffusion coefficient of Ketotifen
was determined for several different concentrations of
immobilised Ketotifen. As shown in Table 1, it was found
that the diffusion coefficient of both membrane systems is
not significantly dependent on the initial concentration of
Ketotifen.
Swelling behaviour (diffusion coefficients of
the solvent)
The dynamic swelling of the CAP (20%) and of the CAB
(20%) network was studied in distilled water in the same
CAP CAB
5 min
24 h
0,00
2,00
4,00
6,00
8,00
% of w ater
Fig. 5 Water sorption of cellulose acetate propionate and cellulose
acetate butyrate membranes at 25 C
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Fig. 6 Variation of log vo with log [Ketotifen] in the release of
Ketotifen from (a) cellulose acetate propionate membranes and (b)
cellulose acetate butyrate membranes
J Mater Sci: Mater Med (2008) 19:677–682 681
123
conditions. The swelling behaviour of CAP and CAB, in
50 cm3 of distilled water was measured and the diffusion
coefficients were determined, as the normalized average of
several experiments, and is presented in Table 2. The data
show that there is an initial linear increase in uptake fol-
lowing a levelling of the solution uptake.
Table 2 shows that the uptake coefficients for the sol-
vent and the diffusion coefficient for the Ketotifen release
are not similar, the solvent uptake being higher. This may
be explained by the relative size of the molecules of solute
and solvent. The water molecules are smaller than Ketot-
ifen and so will diffuse faster.
Conclusions
The results obtained indicate that cellulose acetate propi-
onate and cellulose acetate butyrate based membranes
show promise for the immobilisation of drugs, namely the
important pharmacological Ketotifen, opening the way to
biomedical applications due to their relevant, controllable
swelling transitions.
Although the release of Ketotifen from cellulose acetate
butyrate membranes is higher, the release from the cellu-
lose acetate propionate membranes is slightly more uni-
form and that may be exploited in future medical
applications. The results show also that the sorption of
water in the both cellulose acetate propionate and cellulose
acetate butyrate membranes is quite similar and that the
release characteristics of these systems do not follow a zero
order profile, indicating that the diffusion mechanism may
be Fickian, controlled mainly by the membrane morphol-
ogy.
The observed differences between the cellulose acetate
propionate and cellulose acetate butyrate systems allow an
efficient discrimination of the polymer abilities in terms of
drug release, based in small structural factors that affect the
morphology and physical properties of these cellulose
based polymers, and confirm their potential as medical
drug delivery systems.
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Table 1 Diffusion coefficient of Ketotifen in the cellulose acetate
propionate and cellulose acetate butyrate membranes
Membrane Amount of
immobilized
Ketotifen (mg/g)
Diffusion
coefficient of
Ketotifen D (cm2/s)
Linear
correlation
coefficient r
CAP 20 2.26 · 10–8 0.96
30 1.52 · 10–8 0.95
40 1.67 · 10–8 0.99
CAB 20 1.84 · 10–8 0.98
30 2.65 · 10–8 0.93
40 3.03 · 10–8 0.96
Table 2 Coefficients of the solvent uptake
Membrane Ketotifen release from the
membrane
Solvent uptake coefficient
Diffusion
coefficient of
Ketotifen D
(cm2/s)
Linear
correlation
coefficient
r
Diffusion
coefficient of
solvent D
(cm2/s)
Linear
correlation
coefficient
r
CAP 2.26 · 10–8 0.96 4.38 · 10–7 0.98
CAB 1.84 · 10–8 0.98 5.73 · 10–7 0.99
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